Carnrite Ventures — 2019 Investments
1 investments dated 2019 · listed companies and verified rows first · show all
Orchid Healthorchidhealth.comin𝕏May 2019
Orchid offers whole genome sequencing-based genetic screening of embryos during IVF as well as preconception testing for couples, analyzing DNA to identify predispositions to monogenic diseases, chromosomal abnormalities, and polygenic risks.
BiotechDigital HealthFemTechSan Francisco, US
Alexandra Meyer(President and Chief Executive Officer of Issuer)
BoardEmily Anhalt(Director of Issuer)
Co-investorsBalaji SrinivasanHartmann CapitalPebblebedRefactor Capital
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.